Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2001, for Unitrin, Inc. (Note: The request metadata referenced "KEMPER Corp," but the filing text explicitly identifies the registrant as Unitrin, Inc.). Unitrin operates through three primary segments: Property and Casualty Insurance, Life and Health Insurance, and Consumer Finance. The company also holds significant equity investments in industrial companies, most notably Litton Industries, Inc.
Key Financial Metrics
| Metric | Q1 2001 | Q1 2000 |
|---|---|---|
| Total Revenues | $467.8 million | $479.6 million |
| Net Income | $16.6 million | $41.9 million |
| Diluted EPS | $0.24 | $0.60 |
| Operating Cash Flow | $70.0 million | $47.0 million |
| Total Assets | $6,212.7 million | $6,164.8 million |
| Shareholders' Equity | $1,686.0 million | $1,701.2 million |
| Notes Payable (Debt) | $144.8 million | $180.0 million |
| Cash and Equivalents | $16.5 million | $23.3 million |
Material Changes vs. Prior Period
- Net Income Decline: Net income dropped 60% to $16.6 million, primarily driven by a significant reduction in Net Gains on Sales of Investments, which fell from $36.5 million in Q1 2000 to $1.7 million in Q1 2001. The prior year included a $31.3 million gain from the sale of Baker Hughes stock.
- Equity in Investees: Income from equity investees decreased from $11.0 million to $5.2 million. This was largely due to a $6.5 million loss recorded from UNOVA, Inc. (related to restructuring charges), offsetting gains from Curtiss-Wright and Litton.
- Segment Performance:
- Property & Casualty: Operating loss narrowed to $1.8 million from $7.4 million, aided by lower storm losses ($8.7M vs $17.9M) and improved commercial lines results.
- Life & Health: Operating profit increased slightly to $20.9 million, despite a $18.3 million drop in premiums due to the prior year's sale of The Pyramid Life Insurance Company.
- Consumer Finance: Revenues rose to $38.6 million due to higher loan volumes, though operating profit remained flat at $6.1 million.
- Liquidity: Cash decreased by $6.8 million during the quarter. The company repurchased $10.0 million of its own common stock.
Outlook, Risks, and Unusual Items
- Northrop Grumman/Litton Transaction: In April 2001, Northrop Grumman acquired Litton Industries. Unitrin exchanged its Litton holdings for Northrop stock and $174.8 million in cash. Management estimates a pre-tax accounting gain of $562.1 million (after-tax gain of ~$362.4 million) to be recognized in Q2 2001. While this will boost reported earnings, ongoing annual net income is expected to decrease by ~$12.2 million, while annual after-tax cash flow is expected to increase by ~$26.0 million.
- Legal Proceedings: The company faces consolidated class-action lawsuits regarding alleged racial discrimination in industrial life insurance pricing. A $32.4 million after-tax charge was recorded in 2000 for estimated settlement costs. Management believes defenses are meritorious but settlement discussions are ongoing.
- Unitrin Direct: The new direct-marketing insurance unit recorded an operating loss of $4.1 million due to high up-front marketing costs. Losses are expected to continue for several years as the business scales.
- Debt Capacity: The company has a $440 million revolving credit facility with $296 million unused as of March 31, 2001.
Investor Verification Checklist
- Verify the timing and magnitude of the $562.1 million pre-tax gain from the Litton/Northrop transaction in the upcoming Q2 2001 filing.
- Monitor the status of the industrial life insurance class-action lawsuits and any updates to the $32.4 million reserve established in 2000.
- Assess the trajectory of Unitrin Direct losses and the timeline for profitability given the high acquisition costs.
- Review the impact of the Litton transaction on future dividend income and cash flow stability compared to the previous equity method accounting.
- Confirm the Property & Casualty combined ratio (107.7%) and the effectiveness of rate increases in mitigating non-storm loss severity.